Article
Deregulation of signaling pathways in acute myeloid leukemia.
Seminars in oncology - 1 Aug 2008
Scholl Claudia, Gilliland D Gary, Fröhling Stefan
Abstract excerpt
In acute myeloid leukemia (AML), aberrant signal transduction enhances the survival and proliferation of hematopoietic progenitor cells. Activation of signal transduction in AML may occur through a variety of genetic alterations affecting different signaling molecules, such as the FLT3 and KIT receptor tyrosine kinases (RTKs) and members of the RAS family of guanine nucleotide-binding proteins. These mutant...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
